Galantamine Hydrobromide Patent Expiration
Galantamine Hydrobromide was first introduced by Janssen Pharmaceuticals Inc
Galantamine Hydrobromide Patents
Given below is the list of patents protecting Galantamine Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Razadyne Er | US7160559 | Controlled release galantamine composition |
Dec 20, 2019
(Expired) | Janssen Pharms |
| Razadyne | US6099863 | Fast-dissolving galanthamine hydrobromide tablet |
Jun 06, 2017
(Expired) | Janssen Pharms |
| Razadyne | US6358527 | Fast-dissolving galanthamine hydrobromide tablet |
Jun 06, 2017
(Expired) | Janssen Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Galantamine Hydrobromide's patents.
Latest Legal Activities on Galantamine Hydrobromide's Patents
Given below is the list recent legal activities going on the following patents of Galantamine Hydrobromide.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Jun, 2018 | US7160559 |
| Patent Issue Date Used in PTA Calculation Critical
| 09 Jan, 2007 | US7160559 |
| Recordation of Patent Grant Mailed Critical
| 09 Jan, 2007 | US7160559 |
| Issue Notification Mailed Critical
| 20 Dec, 2006 | US7160559 |
| Dispatch to FDC | 06 Dec, 2006 | US7160559 |
| Mail Miscellaneous Communication to Applicant | 30 Nov, 2006 | US7160559 |
| Miscellaneous Communication to Applicant - No Action Count | 25 Nov, 2006 | US7160559 |
| Mail-Petition Decision - Dismissed Critical
| 19 Sep, 2006 | US7160559 |
| Application Is Considered Ready for Issue Critical
| 04 May, 2006 | US7160559 |
| Issue Fee Payment Verified Critical
| 27 Apr, 2006 | US7160559 |
Galantamine Hydrobromide's Family Patents
